The -74 G/C polymorphism of the interleukin-6 gene promoter is associated with Alzheimer's disease in an Italian population

NeuroReport

Volumn 13, Issue 13, 2002, Pages 1645-1647

  Pola, Roberto ^a   Flex, Andrea ^a   Gaetani, Eleonora ^a   Lago, Antonio Dal ^a   Gerardino, Laura ^a   Pola, Paolo ^a   Bernabei, Roberto ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Alzheimer's disease; Gene polymorphism; IL 6

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0037120334     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200209160-00015     Document Type: Article

References (26)

1. McGeer PL and McGeer EG. Brain Res Rev 21, 195-218 (1995).
2. Kalman J, Juhasz A, Laird G et al. Z Acta Neurol Scand 96, 236-240 (1997).
3. Terreni L and De Simoni MG. Neuroimmunomodulation 5, 214-219 (1998).
4. Hull M, Berger M, Volk B et al. Ann N Y Acad Sci 777, 205-212 (1996).
5. Fishman D, Faulds G, Jeffery R et al. J Clin Invest 102, 1369-1376 (1998).
6. Terry CF, Loukaci V and Green FR. J Biol Chem 275, 18138-18144 (2000).
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. (revised). Washington DC: American Psychiatric Association; 1987.
8. McKhann G, Drachman D, Folstein M et al. Neurology 34, 939-944 (1984).
9. Hachinski VC, Iliff LD, Zilhka E et al. Arch Neurol 32, 632-637 (1975).
10. Fernandez-Real JM, Broch M, Vendrell J et al. J Clin Endocrinol Metab 85, 1134-1139 (2000).
11. Neumann H. Glia 36, 191-199 (2001).
12. Luterman JD, Haroutunian V, Yemul S et al. Arch Neurol 57, 1153-1160 (2000).
13. von Bernhardi R and Ramirez G. Biol Res 34, 123-128 (2001).
14. Walker DG. Inflammatory markers in chronic neurodegenerative disorders with emphasis on Alzheimer's disease. In: Wood PL, ed. Neuroinflammation: Mechanism and Managment. Totowa, NJ: Humana Press; 1998, pp. 61-90.
15. Lee SC, Liu W, Dickson DW et al. J Immunol 150, 2659-2667 (1993).
16. Bauer J, Ganter U, Strauss S et al. Re. Immunol 143, 650-657 (1992).
17. Blum-Degen D, Muller T, Kuhn W et al. Neurosci Lett 202, 17-20 (1995).
18. Tehranian R, Hasanvan H, Iverfeldt K et al. Neurosci Lett 301, 54-58 (2001).
19. Bagli M, Papassotiropoulos A, Knapp M et al. Neurosci Lett 283, 109-112 (2000).
20. Bhojak TJ, DeKosky ST, Ganguli M et al. Neurosci Lett 288, 21-214 (2000).
21. Shibata N, Ohnuma T, Takahashi T et al. Am J Med Genet 114, 436-439 (2002).
22. Goris A, Epplen C, Fiten P et al. J Interferon Cytokine Res 19, 1037-1046 (1999).
23. Falcone E, Spadafora P, De Luca M et al. Hum Biol 67, 689-701 (1995).
24. Vandenbroeck K, Hardt C, Louage J et al. Genes Immun 1, 290-292 (2000).
25. Pallaud C, Stranieri C, Sass C et al. Clin Chem Lab Med 39, 146-154 (2001).
26. Mateo I, Sanchez-Guerra M, Combarros O et al. Am J Med Genet 114, 31-33 (2002).